Troy A. Ignelzi - Net Worth and Insider Trading

Troy A. Ignelzi Net Worth

The estimated net worth of Troy A. Ignelzi is at least $10 Million dollars as of 2024-04-19. Troy A. Ignelzi is the CFO of Karuna Therapeutics Inc and owns about 30,487 shares of Karuna Therapeutics Inc (KRTX) stock worth over $10 Million. Details can be seen in Troy A. Ignelzi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Troy A. Ignelzi has not made any transactions after 2023-08-22 and currently still holds the listed stock(s).

Transaction Summary of Troy A. Ignelzi

Troy A. Ignelzi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Troy A. Ignelzi owns 4 companies in total, including Karuna Therapeutics Inc (KRTX) , scPharmaceuticals Inc (SCPH) , and Esperion Therapeutics Inc (ESPR) among others .

Click here to see the complete history of Troy A. Ignelzi’s form 4 insider trades.

Insider Ownership Summary of Troy A. Ignelzi

Ticker	Comapny	Transaction Date	Type of Owner
KRTX	Karuna Therapeutics Inc	2023-08-22	Chief Financial Officer
SCPH	scPharmaceuticals Inc	2017-11-16	Chief Financial Officer
ESPR	Esperion Therapeutics Inc	2013-06-25	Vice President
CINC	CinCor Pharma Inc	2022-01-06	director

Troy A. Ignelzi Latest Holdings Summary

Troy A. Ignelzi currently owns a total of 1 stock. Troy A. Ignelzi owns 30,487 shares of Karuna Therapeutics Inc (KRTX) as of August 22, 2023, with a value of $10 Million.

Latest Holdings of Troy A. Ignelzi

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
KRTX	Karuna Therapeutics Inc	2023-08-22	30,487	329.83	10,055,527

Holding Weightings of Troy A. Ignelzi

Troy A. Ignelzi Form 4 Trading Tracker

According to the SEC Form 4 filings, Troy A. Ignelzi has made a total of 20 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Karuna Therapeutics Inc is the sale of 1,500 shares on August 22, 2023, which brought Troy A. Ignelzi around $262,680.

Insider Trading History of Troy A. Ignelzi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Troy A. Ignelzi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Troy A. Ignelzi Ownership Network

Ownership Network List of Troy A. Ignelzi

No Data

Ownership Network Relation of Troy A. Ignelzi

Troy A. Ignelzi Owned Company Details

What does Karuna Therapeutics Inc do?

Who are the key executives at Karuna Therapeutics Inc?

Troy A. Ignelzi is the Chief Financial Officer of Karuna Therapeutics Inc. Other key executives at Karuna Therapeutics Inc include Chief Medical Officer Stephen K. Brannan , Chief Financial Officer Jason Parker Brown , and Chief Operating Officer Andrew Craig Miller .

Karuna Therapeutics Inc (KRTX) Insider Trades Summary

Over the past 18 months, Troy A. Ignelzi made 5 insider transaction in Karuna Therapeutics Inc (KRTX) with a net sale of 34,017. Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 85,000 shares made by Stephen K. Brannan , a net sale of 90,000 shares made by Andrew Craig Miller , and a net sale of 41,429 shares made by Jeffrey M Jonas .

In summary, during the past 3 months, insiders sold 10,000 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 257,473 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 257,473 shares.

Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Karuna Therapeutics Inc Insider Transactions

No Available Data

What does scPharmaceuticals Inc do?

Who are the key executives at scPharmaceuticals Inc?

Troy A. Ignelzi is the Chief Financial Officer of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .

scPharmaceuticals Inc (SCPH) Insider Trades Summary

Over the past 18 months, Troy A. Ignelzi made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 762,380 shares made by Orbimed Advisors Llc ,

In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 762,380 shares were bought by its insiders, resulting in a net purchase of 762,380 shares.

scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

scPharmaceuticals Inc Insider Transactions

No Available Data

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Troy A. Ignelzi is the Vice President of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Troy A. Ignelzi made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Esperion Therapeutics Inc Insider Transactions

No Available Data

What does CinCor Pharma Inc do?

Who are the key executives at CinCor Pharma Inc?

Troy A. Ignelzi is the director of CinCor Pharma Inc. Other key executives at CinCor Pharma Inc include director & 10 percent owner James Healy , 10 percent owner Sofinnova Management X-a, L.l.c. , and EVP & Chief Financial Officer Michael Wayne Kalb .

CinCor Pharma Inc (CINC) Insider Trades Summary

Over the past 18 months, Troy A. Ignelzi made no insider transaction in CinCor Pharma Inc (CINC). Other recent insider transactions involving CinCor Pharma Inc (CINC) include a net sale of 6,000 shares made by James Healy ,

In summary, during the past 3 months, insiders sold 0 shares of CinCor Pharma Inc (CINC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000 shares of CinCor Pharma Inc (CINC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000 shares.

CinCor Pharma Inc (CINC)'s detailed insider trading history can be found in Insider Trading Tracker table.

CinCor Pharma Inc Insider Transactions

No Available Data

Troy A. Ignelzi Mailing Address

Above is the net worth, insider trading, and ownership report for Troy A. Ignelzi. You might contact Troy A. Ignelzi via mailing address: C/o Esperion Therapeutics, Inc., 46701 Commerce Center Drive, Plymouth Mi 48170.

Discussions on Troy A. Ignelzi

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.